Characterization of a single mutation in TraQ in a strain of Escherichia coli partially resistant to Qβ infection

Frontiers in Microbiology
Akiko KashiwagiFumie Sano Tsushima

Abstract

Bacteria and virulent bacteriophages are in a prey-predator relationship. Experimental models under simplified conditions with the presence of bacteria and bacteriophages have been used to elucidate the mechanisms that have enabled both prey and predator to coexist over long periods. In experimental coevolution conducted with Escherichia coli and the virulent RNA bacteriophage Qβ in serial transfer, both coexisted for at least for 54 days, during which time they continued to change genetically and phenotypically. By day 16, an E. coli strain partially resistant to Qβ appeared and caused an approximately 10(4)-fold decrease in Qβ amplification. Whole-genome analysis of this strain suggested that a single mutation in TraQ was responsible for the partially resistant phenotype. TraQ interacts with propilin, encoded by the traA gene and a precursor of pilin, which is a component of the F pilus. The present study was performed to elucidate the mechanism underlying the coexistence of E. coli and Qβ by investigating how a mutation in TraQ altered the physiological state of E. coli, and thus the amplification of Qβ. Overexpression of wild-type TraQ in the partially resistant E. coli strain resulted in recovery of both TraA protein conte...Continue Reading

References

Dec 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·F SangerA R Coulson
Jan 1, 1979·Microbiology and Immunology·I WatanabeA Ando
Mar 1, 1975·Journal of Bacteriology·R E Hancock, P Reeves
Jan 1, 1982·Molecular & General Genetics : MGG·D MooreK Ippen-Ihler
Jan 1, 1981·Annual Review of Microbiology·M Alexander
Oct 1, 1995·Applied and Environmental Microbiology·M A MoranR E Hodson
Mar 1, 1993·Journal of Bacteriology·K ManeewannakulK Ippen-Ihler
Nov 24, 1999·Molecular Microbiology·R L HarrisP M Silverman
Jun 21, 2001·Proceedings. Biological Sciences·A Sasaki
May 25, 2002·Proceedings. Biological Sciences·Angus Buckling, Paul B Rainey
Aug 17, 2002·Science·Michael B ElowitzPeter S Swain
May 14, 2004·Theoretical Population Biology·Cheryl J Briggs, Martha F Hoopes
Apr 8, 2006·Journal of Evolutionary Biology·M A BrockhurstP B Rainey
Nov 14, 2008·Proceedings of the National Academy of Sciences of the United States of America·Margaret ClarkePhilip M Silverman
Feb 26, 2010·Nature·Steve PatersonMichael A Brockhurst
Mar 30, 2010·Nature Reviews. Microbiology·Simon J LabrieSylvain Moineau
May 18, 2010·Integrative Biology : Quantitative Biosciences From Nano to Macro·Philip M Silverman, Margaret B Clarke
Jul 16, 2011·Oecologia·Nathalie PettorelliJean-Michel Gaillard
Nov 15, 2011·Current Opinion in Immunology·David Bikard, Luciano A Marraffini
Mar 6, 2012·Proceedings of the National Academy of Sciences of the United States of America·Marcia F MarstonJennifer B H Martiny
Dec 6, 2012·International Journal of Evolutionary Biology·John J Dennehy
Mar 26, 2013·Trends in Ecology & Evolution·Michael A Brockhurst, Britt Koskella

❮ Previous
Next ❯

Datasets Mentioned

BETA
AP001918.1

Methods Mentioned

BETA
PCR
X-ray

Related Concepts

Related Feeds

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.